Correlation Between Pulmatrix and Cyteir Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pulmatrix and Cyteir Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pulmatrix and Cyteir Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pulmatrix and Cyteir Therapeutics, you can compare the effects of market volatilities on Pulmatrix and Cyteir Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pulmatrix with a short position of Cyteir Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pulmatrix and Cyteir Therapeutics.

Diversification Opportunities for Pulmatrix and Cyteir Therapeutics

0.61
  Correlation Coefficient

Poor diversification

The 3 months correlation between Pulmatrix and Cyteir is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Pulmatrix and Cyteir Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyteir Therapeutics and Pulmatrix is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pulmatrix are associated (or correlated) with Cyteir Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyteir Therapeutics has no effect on the direction of Pulmatrix i.e., Pulmatrix and Cyteir Therapeutics go up and down completely randomly.

Pair Corralation between Pulmatrix and Cyteir Therapeutics

Given the investment horizon of 90 days Pulmatrix is expected to generate 2.74 times less return on investment than Cyteir Therapeutics. In addition to that, Pulmatrix is 1.05 times more volatile than Cyteir Therapeutics. It trades about 0.04 of its total potential returns per unit of risk. Cyteir Therapeutics is currently generating about 0.11 per unit of volatility. If you would invest  136.00  in Cyteir Therapeutics on August 26, 2024 and sell it today you would earn a total of  140.00  from holding Cyteir Therapeutics or generate 102.94% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy31.79%
ValuesDaily Returns

Pulmatrix  vs.  Cyteir Therapeutics

 Performance 
       Timeline  
Pulmatrix 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Pulmatrix are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of very weak essential indicators, Pulmatrix displayed solid returns over the last few months and may actually be approaching a breakup point.
Cyteir Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cyteir Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Cyteir Therapeutics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Pulmatrix and Cyteir Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pulmatrix and Cyteir Therapeutics

The main advantage of trading using opposite Pulmatrix and Cyteir Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pulmatrix position performs unexpectedly, Cyteir Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyteir Therapeutics will offset losses from the drop in Cyteir Therapeutics' long position.
The idea behind Pulmatrix and Cyteir Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Content Syndication
Quickly integrate customizable finance content to your own investment portal